Ashli A Owen-Smith1, Joseph Gerth2, R Craig Sineath3, Joshua Barzilay4, Tracy A Becerra-Culqui5, Darios Getahun5, Shawn Giammattei6, Enid Hunkeler7, Timothy L Lash2, Andrea Millman8, Rebecca Nash2, Virginia P Quinn9, Brandi Robinson4, Douglas Roblin10, Travis Sanchez2, Michael J Silverberg8, Vin Tangpricha11, Cadence Valentine5, Savannah Winter4, Cory Woodyatt2, Yongjia Song2, Michael Goodman2. 1. Department of Health Management and Policy, School of Public Health, Georgia State University, Atlanta, GA; Center for Clinical and Outcomes Research, Kaiser Permanente Georgia, Atlanta, GA. Electronic address: aowensmith@gsu.edu. 2. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA. 3. School of Medicine, Emory University, Atlanta, GA. 4. Center for Clinical and Outcomes Research, Kaiser Permanente Georgia, Atlanta, GA. 5. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA. 6. Rockway Institute, Alliant International University, San Francisco, CA. 7. Emeritus, Division of Research, Kaiser Permanente Northern California, Oakland, CA. 8. Division of Research, Kaiser Permanente Northern California, Oakland, CA. 9. Emeritus, Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA. 10. Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, MD. 11. School of Medicine, Emory University, Atlanta, GA; Atlanta US Department of Veterans Affairs Medical Center, Atlanta, GA.
Abstract
BACKGROUND: Transgender individuals sometimes seek gender confirmation treatments (GCT), including hormone therapy (HT) and/or surgical change of the chest and genitalia ("top" and "bottom" gender confirmation surgeries). These treatments may ameliorate distress resulting from the incongruence between one's physical appearance and gender identity. AIM: The aim was to examine the degree to which individuals' body-gender congruence, body image satisfaction, depression, and anxiety differed by GCT groups in cohorts of transmasculine (TM) and transfeminine (TF) individuals. METHODS: The Study of Transition, Outcomes, and Gender is a cohort study of transgender individuals recruited from 3 health plans located in Georgia, Northern California, and Southern California; cohort members were recruited to complete a survey between 2015-2017. Participants were asked about: history of GCT; body-gender congruence; body image satisfaction; depression; and anxiety. Participants were categorized as having received: (1) no GCT to date; (2) HT only; (3) top surgery; (4) partial bottom surgery; and (5) definitive bottom surgery. OUTCOMES: Outcomes of interest included body-gender congruence, body image satisfaction, depression, and anxiety. RESULTS: Of the 2,136 individuals invited to participate, 697 subjects (33%) completed the survey, including 347 TM and 350 TF individuals. The proportion of participants with low body-gender congruence scores was significantly higher in the "no treatment" group (prevalence ratio [PR] = 3.96, 95% CI 2.72-5.75) compared to the definitive bottom surgery group. The PR for depression comparing participants who reported no treatment relative to those who had definitive surgery was 1.94 (95% CI 1.42-2.66); the corresponding PR for anxiety was 4.33 (95% CI 1.83-10.54). CLINICAL TRANSLATION: Withholding or delaying GCT until depression or anxiety have been treated may not be the optimal treatment course given the benefits of reduced levels of distress after undergoing these interventions. CONCLUSIONS: Strengths include the well-defined sampling frame, which allowed correcting for non-response, a sample with approximately equal numbers of TF and TM participants, and the ability to combine data on HT and gender confirmation surgeries. Limitations include the cross-sectional design and the fact that participants may not be representative of the transgender population in the United States. Body-gender congruence and body image satisfaction were higher, and depression and anxiety were lower among individuals who had more extensive GCT compared to those who received less treatment or no treatment at all. Owen-Smith AA, Gerth J, Sineath RC, et al. Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction and Mental Health in a Cohort Of Transgender Individuals. J Sex Med 2018;15:591-600.
BACKGROUND: Transgender individuals sometimes seek gender confirmation treatments (GCT), including hormone therapy (HT) and/or surgical change of the chest and genitalia ("top" and "bottom" gender confirmation surgeries). These treatments may ameliorate distress resulting from the incongruence between one's physical appearance and gender identity. AIM: The aim was to examine the degree to which individuals' body-gender congruence, body image satisfaction, depression, and anxiety differed by GCT groups in cohorts of transmasculine (TM) and transfeminine (TF) individuals. METHODS: The Study of Transition, Outcomes, and Gender is a cohort study of transgender individuals recruited from 3 health plans located in Georgia, Northern California, and Southern California; cohort members were recruited to complete a survey between 2015-2017. Participants were asked about: history of GCT; body-gender congruence; body image satisfaction; depression; and anxiety. Participants were categorized as having received: (1) no GCT to date; (2) HT only; (3) top surgery; (4) partial bottom surgery; and (5) definitive bottom surgery. OUTCOMES: Outcomes of interest included body-gender congruence, body image satisfaction, depression, and anxiety. RESULTS: Of the 2,136 individuals invited to participate, 697 subjects (33%) completed the survey, including 347 TM and 350 TF individuals. The proportion of participants with low body-gender congruence scores was significantly higher in the "no treatment" group (prevalence ratio [PR] = 3.96, 95% CI 2.72-5.75) compared to the definitive bottom surgery group. The PR for depression comparing participants who reported no treatment relative to those who had definitive surgery was 1.94 (95% CI 1.42-2.66); the corresponding PR for anxiety was 4.33 (95% CI 1.83-10.54). CLINICAL TRANSLATION: Withholding or delaying GCT until depression or anxiety have been treated may not be the optimal treatment course given the benefits of reduced levels of distress after undergoing these interventions. CONCLUSIONS: Strengths include the well-defined sampling frame, which allowed correcting for non-response, a sample with approximately equal numbers of TF and TM participants, and the ability to combine data on HT and gender confirmation surgeries. Limitations include the cross-sectional design and the fact that participants may not be representative of the transgender population in the United States. Body-gender congruence and body image satisfaction were higher, and depression and anxiety were lower among individuals who had more extensive GCT compared to those who received less treatment or no treatment at all. Owen-Smith AA, Gerth J, Sineath RC, et al. Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction and Mental Health in a Cohort Of Transgender Individuals. J Sex Med 2018;15:591-600.
Authors: Larry Nuttbrock; Walter Bockting; Andrew Rosenblum; Sel Hwahng; Mona Mason; Monica Macri; Jeffrey Becker Journal: Am J Public Health Date: 2013-12-12 Impact factor: 9.308
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: S Manne; N Nereo; K DuHamel; J Ostroff; S Parsons; R Martini; S Williams; L Mee; S Sexson; J Lewis; S J Vickberg; W H Redd Journal: J Consult Clin Psychol Date: 2001-12
Authors: Larry Nuttbrock; Walter Bockting; Andrew Rosenblum; Sel Hwahng; Mona Mason; Monica Macri; Jeffrey Becker Journal: Am J Public Health Date: 2012-06-14 Impact factor: 9.308
Authors: Tim C van de Grift; Peggy T Cohen-Kettenis; Thomas D Steensma; Griet De Cuypere; Hertha Richter-Appelt; Ira R H Haraldsen; Rieky E G Dikmans; Susanne C Cerwenka; Baudewijntje P C Kreukels Journal: Arch Sex Behav Date: 2015-10-16
Authors: Joseph Gerth; Tracy Becerra-Culqui; Andrew Bradlyn; Darios Getahun; Enid M Hunkeler; Timothy L Lash; Andrea Millman; Rebecca Nash; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Vin Tangpricha; Suma Vupputuri; Michael Goodman Journal: Rev Endocr Metab Disord Date: 2018-09 Impact factor: 6.514
Authors: Howa Yeung; Laura Ragmanauskaite; Qi Zhang; Jin Kim; Vin Tangpricha; Darios Getahun; Michael J Silverberg; Michael Goodman Journal: J Am Acad Dermatol Date: 2020-02-25 Impact factor: 11.527
Authors: Josephine Mak; Deirdre A Shires; Qi Zhang; Lucas R Prieto; Brian K Ahmedani; Leonardo Kattari; Tracy A Becerra-Culqui; Andrew Bradlyn; W Dana Flanders; Darios Getahun; Shawn V Giammattei; Enid M Hunkeler; Timothy L Lash; Rebecca Nash; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Jennifer Slovis; Vin Tangpricha; Suma Vupputuri; Michael Goodman Journal: Am J Prev Med Date: 2020-08-12 Impact factor: 5.043
Authors: Hillary B Nguyen; Alexis M Chavez; Emily Lipner; Liisa Hantsoo; Sara L Kornfield; Robert D Davies; C Neill Epperson Journal: Curr Psychiatry Rep Date: 2018-10-11 Impact factor: 5.285
Authors: Alexandra Junn; Sumun Khetpal; John Smetona; Jacob Dinis; Allister Hirschman; Mohammad Ali Mozaffari; Anusha Singh; Ann Hui Ching; Michael Alperovich; Xiaona Lu; John A Persing Journal: Ann Transl Med Date: 2021-04
Authors: Margaret To; Qi Zhang; Andrew Bradlyn; Darios Getahun; Shawn Giammattei; Rebecca Nash; Ashli A Owen-Smith; Douglas Roblin; Michael J Silverberg; Vin Tangpricha; Suma Vupputuri; Michael Goodman Journal: J Sex Med Date: 2020-08-15 Impact factor: 3.802